.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

DISIPAL Drug Profile

« Back to Dashboard
Disipal is a drug marketed by 3M and is included in one NDA.

The generic ingredient in DISIPAL is orphenadrine hydrochloride. There are nine drug master file entries for this compound. Additional details are available on the orphenadrine hydrochloride profile page.

Summary for Tradename: DISIPAL

Patents:0
Applicants:1
NDAs:1

Clinical Trials for: DISIPAL

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m
DISIPAL
orphenadrine hydrochloride
TABLET;ORAL010653-001Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc